StocksMedium•7 October 2026•
1 min read
Profound Medical Q3 Preliminary Revenue Beats Estimates by 45%
Key Facts
1Profound Medical anticipates Q3 2026 revenue to be between $9.8 million and $10.0 million.
2The anticipated revenue exceeds Bloomberg analyst consensus by approximately 45% to 47%.
Profound Medical anticipates Q3 2026 revenue to be between $9.8 million and $10.0 million. According to a statement released via GlobeNewswire, these preliminary figures exceed Bloomberg analyst consensus estimates by approximately 45% to 47%.
PROF closed at $6.08 on October 6, 2026, having traded between a day high of $6.34 and a day low of $6.01 during that session. The anticipated revenue beat highlights significant commercial momentum ahead of the company's full quarterly financial report scheduled for November.